The Indian pharmaceutical sector displayed mixed performance in early trading on February 6, 2026, as of approximately 10:00 AM IST. Data from BSE and NSE shows most listed pharma stocks trading with negative changes, aligning with broader market trends where the Nifty 50 was down around 0.35% and the Sensex declined modestly. The Nifty Pharma index closed the previous session (February 5, 2026) near 22,119.90 with minimal change (-0.03%), indicating limited sector momentum heading into the day.
The provided snapshot reflects prices and percentage changes around 9:59-10:00 AM IST on February 6, 2026.
Key Observations from Early Trading
- Overall Trend: The majority of pharma stocks were in the red, with declines ranging from minor (under 1%) to significant (over 3-6% in some cases). This suggests downward pressure on the sector during the opening hours.
- Notable Gainers (positive or minimal decline):
- Concord Biotech: +3.42% (BSE), +4.61% (NSE)
- Aster DM Healthcare: +2.69% (BSE), +2.79% (NSE)
- Metropolis Healthcare: +2.34% (BSE), +1.77% (NSE)
- Dr. Lal Pathlabs: +1.46% (BSE), +1.37% (NSE)
- Jeena Sikho: +1.70% (BSE)
- Yatharth Hospital: +3.15% (BSE)
- Sai Life Sciences: +2.95% (BSE)
- Sudeep Pharma: +3.35% (BSE)
- Shukra Pharma: +5.00% (BSE, though low liquidity possible)
- Notable Losers (larger declines):
- Unichem Lab: -6.14% (BSE)
- Alembic Pharma: -3.39% (BSE), -4.04% (NSE)
- Alivus Life Sciences: -3.50% (BSE)
- FDC: -3.35% (BSE)
- Marksans Pharma: -3.48% (BSE)
- Morepen Labs: -3.48% (BSE)
- Sequent Scientific: -3.68% (BSE)
- Suven Life Sciences: -3.90% (BSE)
- Syngene International: -3.31% (BSE)
- Divi’s Laboratories: -2.43% (BSE)
- Jubilant Industries: -4.08% (BSE)
- Major Large-Cap Stocks:
- Sun Pharma: -0.38% (BSE), -0.41% (NSE)
- Cipla: -0.90% (BSE)
- Dr. Reddy’s Lab: -0.96% (BSE)
- Torrent Pharma: -0.78% (BSE)
- Zydus Lifesciences: -1.96% (BSE)
- Lupin: -1.47% (BSE)
This data captures intraday levels shortly after market open and may change as trading progresses. For real-time updates, refer to official NSE/BSE platforms or financial data providers.